Polaris Venture Management Co. V, L.L.C. - Q4 2018 holdings

$93.7 Million is the total value of Polaris Venture Management Co. V, L.L.C.'s 12 reported holdings in Q4 2018. The portfolio turnover from Q3 2018 to Q4 2018 was 0.0% .

 Value Shares↓ Weighting
CDLX  Cardlytics, Inc.$27,645,000
-56.7%
2,552,6260.0%29.51%
-7.8%
FATE SellFate Therapeutics, Inc.$23,391,000
-41.9%
1,823,186
-26.3%
24.97%
+23.8%
STIM  Neuronetics, Inc.$15,959,000
-39.6%
824,7650.0%17.04%
+28.7%
KALA  Kala Pharmaceuticals, Inc.$9,084,000
-50.5%
1,857,5820.0%9.70%
+5.6%
TTOO  T2 Biosystems, Inc.$5,544,000
-59.6%
1,841,9240.0%5.92%
-13.9%
ASNS  Arsanis, Inc.$4,336,000
+43.2%
1,868,9570.0%4.63%
+205.3%
SELB  Selecta Biosciences, Inc.$4,274,000
-82.9%
1,606,8130.0%4.56%
-63.5%
LIFE  Atyr Pharma Inc.$906,000
-39.0%
1,827,9920.0%0.97%
+30.1%
TRVN  Trevena, Inc.$883,000
-79.7%
2,053,5400.0%0.94%
-56.7%
PULM  Pulmatrix, Inc.$863,000
-35.1%
3,594,3810.0%0.92%
+38.3%
GNCA  Genocea Biosciences, Inc.$565,000
-63.2%
1,968,6060.0%0.60%
-21.5%
DARE  Dare Bioscience, Inc.$232,000
-27.0%
326,2430.0%0.25%
+56.0%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2019-02-14
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
Fate Therapeutics, Inc.30Q2 202179.2%
Atyr Pharma Inc.26Q3 202115.1%
Trevena, Inc.22Q2 201924.9%
Genocea Biosciences, Inc.21Q1 201932.5%
Selecta Biosciences, Inc.20Q1 202139.5%
T2 Biosystems, Inc.20Q2 201936.1%
Dare Bioscience, Inc.17Q3 20213.9%
Pulmatrix, Inc.16Q1 201915.4%
Cerulean Pharma Inc13Q2 201716.2%
Kala Pharmaceuticals, Inc.11Q1 202037.1%

View Polaris Venture Management Co. V, L.L.C.'s complete holdings history.

Latest filings
TypeFiled
32022-03-30
13F-HR2021-11-12
13F-HR2021-08-12
13F-HR2021-05-12
13F-HR2021-02-12
13F-HR2020-11-12
13F-HR2020-08-12
13F-HR2020-05-14
42020-05-06
32020-04-30

View Polaris Venture Management Co. V, L.L.C.'s complete filings history.

Compare quarters

Export Polaris Venture Management Co. V, L.L.C.'s holdings